金吾财讯 | 香港创新科技署今日（9月3日）宣布，“创新及科技基金”下“新型工业评审委员会”（评审委员会）已原则上支持三宗分别由九华华源药业股份有限公司旗下华药国际有限公司、港芯国际科技有限公司，以及中国建筑国际集团有限公司旗下香港智能建造产业园有限公司提交的“新型工业加速计划”（“加速计划”）申请。华药国际有限公司拟建立保健品生产线，总预算投资金额超过二亿四千万元，预计“加速计划”资助金额约八千万元。港芯国际科技有限公司拟建立半导体记忆体模组及存储装置生产线，总预算投资金额超过二亿一千万元，预计“加速计划”资助金额约七千万元。而香港智能建造产业园有限公司拟建立钢筋预制及机电装备合成加工设施，总预算投资金额接近三亿九千万元，预计“加速计划”资助金额约一亿三千万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.